A listing is worth more when you extract the schedule, eligibility rules, site identity, procedure burden, and payment questions before calling.
Write down the official title, NCT number, sponsor, condition, intervention, site location, and recruitment status. Confirm whether the listing is recruiting at the location you can actually reach. Large studies may list many locations, and some locations may not be open at the same time.
Look for the study phase and intervention type. A questionnaire study, observational registry, device study, drug study, vaccine study, imaging study, and inpatient pharmacokinetic study can all have very different obligations.
Words like “may,” “up to,” “approximately,” “eligible participants,” and “compensation available” need clarification. Ask what usually happens, what triggers extra visits, and what the payment schedule looks like in normal cases. If a listing says “remote visits,” ask whether any in-person screening, labs, imaging, or final visits are still required.
Outcome measures often reveal what the study must measure repeatedly. Blood levels may mean repeated blood draws. Symptom scores may mean diaries or questionnaires. Imaging outcomes may mean scans at specific visits. Device outcomes may mean training, use logs, or troubleshooting. When the procedures are unclear, ask how each outcome is measured and how often.
Clear site identity, clear schedule, official identifier, understandable eligibility rules, written payment schedule, secure records process, and a coordinator who answers direct questions.
Compensation emphasized without schedule details, vague remote language, missing location details, broad record requests, unclear reimbursement, or eligibility rules that mention medications or labs you know may apply to you.
Call with the listing open. Ask the coordinator to confirm the current status, visit schedule, screening payment, main exclusions, and whether the consent form can be reviewed before a full screening appointment.
